跳至主要内容
临床试验/NCT06881979
NCT06881979招募中不适用

Clinical Protocol for a Pragmatic Trial on a High-Tech Rehabilitation Pathway for Chronic Adult Neuromuscular Diseases (Fit4MedRob-Chronic MND Project)

Istituti Clinici Scientifici Maugeri SpA7 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年4月28日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
60
试验地点
7
主要终点
Change from baseline in Fatigue Severity Scale

研究概览

简要总结

The primary objective is to demonstrate, in a population of chronic neuromuscular disease the non-inferiority of a rehabilitation treatment integrated with robotic and/or technological devices compared to traditional rehabilitation treatment in the level of fatigue.

The main question it aims to answer is:

Are high-tech rehabilitation interventions, including robotic systems, virtual reality, and stabilometric platforms, not inferior to traditional rehabilitation methods in improving balance, motor function, fatigue levels, sarcopenia, cognitive engagement, and overall quality of life in patients with chronic neuromuscular diseases (NMDs)? Researchers will compare a robotic treatment group, that consists in an high-tech rehabilitation, with a control group, that will receive the traditional rehabilitative treatment.

详细描述

Objective

To evaluate the efficacy of a novel rehabilitation protocol integrating advanced technologies in the treatment of chronic neuromuscular diseases (NMDs).

Background: NMDs affect muscle function and are directly controlled by the nervous system. Traditional rehabilitation often falls short in addressing the multifaceted needs of NMD patients. This gap underscores the necessity for innovative rehabilitation approaches that can significantly enhance the quality of life and optimize recovery outcomes following acute events.

Methods: The protocol integrates advanced technologies to address the rehabilitation needs of patients with chronic NMDs. It utilizes robotic systems to ensure consistent and precise movement, virtual reality for immersive and engaging therapy, and stabilometric platforms to enhance balance training. The focus is on chronic NMDs such as Amyotrophic Lateral Sclerosis (ALS), Chronic Inflammatory Demyelinating Polyneuropathy (CIPD) and Charcot-Marie-Tooth neuropathy (CMT). The approach emphasizes rapid rehabilitation to maximize recovery outcomes.

Study Design: An interventional, randomized, pragmatic trial with a parallel assignment. The trial aims to compare the efficacy of high-tech rehabilitation methods against conventional treatments in improving patient outcomes.

Outcome Measures: To assess the improvement of at least 10 points in balance measured using the Berg Balance Scale (BBS) from baseline to the end of the treatment period comparing the high-tech rehabilitation circuit with standard rehabilitation protocol. Conclusion: This protocol seeks to determine if high-tech rehabilitation interventions can outperform traditional methods in chronic NMDs. By doing so, it aims to potentially establish a new global standard for the care of patients with NMD care.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Double (Investigator, Outcomes Assessor)

盲法说明

Masking Description

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients with a confirmed diagnosis of chronic neuromuscular diseases (e.g. ALS, CIDP, CMT)
  • •Patient able to walk independently or with assistance
  • •Patients capable of understanding and adhering to the study protocol.
  • •Patients who have provided informed consent to participate in the study

排除标准

  • •Patients with unstable medical conditions (e.g. severe cardiovascular diseases, such as "New York Heart Association" - NYHA=4, respiratory distress not compensated by ventilation) that could interfere, in the clinician's judgment, with their ability to safely participate in the study or to perform the assessments related to the protocol.
  • •Patients currently participating in other clinical trials that could interfere with this study.
  • •Pregnant women.

研究组 & 干预措施

Control group

Other

The patients will receive the traditional rehabilitative treatment according to the good clinical practice according to the Diagnostic, Therapeutic and Care Pathways of each center involved

干预措施: Rehabilitation (Other)

Robotic treatment group

Active Comparator

In this arm, patients will undergo in motor and cognitive exercise using the VR device (e.g., VRRS EVO), treatment with proprioceptive exercises on a platform (e.g., GEA MASTER or PROKIN Technobody) to enhance postural control, aerobic exercises on a robotic treadmill (e.g. Walkerview Technobody) and usual physiotherapy treatment, such as passive and active assisted exercises

干预措施: High-tech rehabilitative treatment (Device)

结局指标

主要结局

Change from baseline in Fatigue Severity Scale

时间窗: At day 0, at day 15, at day 30, at day 45, at day 60

The Fatigue Severity Scale questionnaire contains nine statements that rate the severity of the fatigue symptoms (from 1 to 7, where 1 means complete disagreement with the statement and 7 means complete agreement).

次要结局

  • Change from baseline in Time Up and Go Test(At day 0, at day 15, at day 30, at day 45, at day 60)
  • Change from baseline in 2-Minute Walking Test(At day 0, at day 15, at day 30, at day 45, at day 60)
  • Change from baseline in 12-Item Short Form Survey (SF-12)(At day 0, at day 30 and day 60)
  • Change from baseline in Technology Assisted Rehabilitation Patient Perception Questionnaire(At day 0, at day 30, at day 60)
  • Change from baseline in Charcot-Marie-Tooth disease neuropathy score(At day 0, day 30 and day 60)
  • Change from baseline in Amyotrophic Lateral Sclerosis Functional Rating Scale Revised(At day 0, at day 30 and at day 60)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (7)

Loading locations...

相似试验